Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Resmed (RSMDF) Cash from Restructuring (2023)

Historic Cash from Restructuring for Resmed (RSMDF) over the last 1 years, with Q2 2023 value amounting to $9.2 million.

  • Resmed's Cash from Restructuring changed N/A to $9.2 million in Q2 2023 from the same period last year, while for Mar 2025 it was $9.2 million, marking a year-over-year change of. This contributed to the annual value of $33.2 million for FY2024, which is 26219.9% up from last year.
  • According to the latest figures from Q2 2023, Resmed's Cash from Restructuring is $9.2 million.
  • In the past 5 years, Resmed's Cash from Restructuring registered a high of $9.2 million during Q2 2023, and its lowest value of $9.2 million during Q2 2023.